Hasil Pencarian  ::  Simpan CSV :: Kembali

"Daun keji beling merupakan salah satu tanaman herbal yang bermanfaat sebagai antihiperkolesterolemia, dimana dalam ekstraknya mengandung senyawa fenolik dan flavonoid. Pada penelitian ini, ekstrak didapatkan dengan metode ekstraksi UAEATPE (Ultrasound-Assisted Enzymatic Aqueos Two Phase Extraction). Proses pra-perlakuan dilakukan dengan hidrolisis enzimatik menggunakan enzim selulase. Proses ekstraksi dilakukan dengan sistem ATPS etanol-garam ammonium sulfat, dimana konsentrasi masing-masing adalah 33% w/w dan 14% w/w. Proses ekstraksi menghasilkan yield ekstrak rata-rata sebesar 59%. Nilai TPC (Total Phenolic Content) dan TFC (Total Flavonoid Content) pada crude ekstrak dianalisis menggunakan spektrofotmetri UV-Vis, dengan panjang gelombang masing-masing 765 nm dan 434 nm. Masing-masing nilai TPC pada fasa atas dan fasa bawah didapatkan sebesar 4,15 mg GAE/g sampel dan 1,08 mg GAE/g sampel. Sedangkan nilai TFC yang diperoleh adalah 1,88 mg QE/g sampel pada fasa atas; serta 0,29 mg QE/g sampel pada fasa bawah. Nilai perolehan (R) dan koefisien partisi (K) yang diperoleh yaitu sebesar 79,29% dan 2,22 untuk fenolik; serta 86,66% dan 3,78 untuk flavonoid, dimana semakin besar nilai koefisien partisi, semakin baik pemisahan yang terjadi. Hasil analisis Gas Chromatography dan Mass Spectrometry (GC-MS) dari ekstrak etanol daun keji beling yang memiliki aktivitas anti-hiperkolesterolemia adalah 1-Docosanol.

---

Keji beling leaves are one of the herbal plant that has benefit as an anti-hypercholesterolemia, in which the leave’s extract contain a phenolic and flavonoid compound. In this study, extract were obtained by extraction using the UAEATPE (Ultrasound-Assisted Enzymatic Aqueous Two Phase Extraction) method. Pre-treatment process was done with hydrolysis enzymatic using enzyme cellulose. Extraction process were done with ethanol-ammonium sulfate salt ATPS system, where the concentrations were 33% w/w and 14% w/w, respectively. The result from extraction process are an average yield extract of 59%. The TPC and TFC values in crude extract were analyzed using UV-Vis spectrophotometry, with a wavelength of 765 nm 434 nm, respectively. Each TPC values on the top and bottom phases obtained were 4.15 mg GAE/g sample and 1.08mg GAE/g sample. Meanwhile, the TFC values obtained were 1.88mg QE/g sample for top phase; and 0.29 mg QE/g sample for bottom phase. The recovery value and partition coefficients values are 79.29% and 2.22 for phenolic; and 86.66% and 3.78 for flavonoid, respectively. In which indicate the bigger the partition coefficients values, the better the separation occurred. The analysis result of ethanol extract of keji beling leaves with Gas Chromatography and Mass Spectrometry (GC-MS) which has anti-hypercholesterolemia activity is 1-Docosanol."

"Penelitian uji klinis paralel, tertutup tunggal, alokasi acak, untuk membandingkan kadar malondialdehida usila 260 tahtm dcngan hiperkolestcrolcmia yang mendapatkan kombinasi suplementasi vitamin E 400 IU dan vitamin C 500 mg, masing-masing sebutir sehari selama 45 hari dengan kelompok yang mendapat vitamin E 400 IU dan plasebo.Terdapat 42 subyek penelitian yang herasal dari Yayasan Kebagusan, Yayasan Yasni, dan Yayasan Yakin, Pasar Minggu Jakarta Selatan yang dibagi menjadi dua kelompok masing-masing benjurnlah 21 orang. Data yang diambil adalah : data demografi, antropometri, data asupan makanan pada minggu pertama, ketiga dan ketujuh, kadar kolesterol LDL dan MDA plasma sebclum dan sesudah perlakuan. Uji statistik yang digunakan adalah uji t-tidak berpasangan bila distribusi normal dan uji Mann-whitney bila distrihusi tidak nom1aI dcngan tingkat kernaknaan p<0.05. Sebanyak 20 subyek penelitian dari masing-masing kelompok yang dapat mengikuti penelitian sampai selesai. Sebeltun perlakuan, nilai median kadar kolesterol LDL kelompok vitamin E+plasebo dan vitamin E4-C masing- masing adalah l46.50(l30-190) mg/dL dan l46.50(l3l-196) mg/dL. Setelah 45 hari perlakuan, rerata kadar kolesterol LDL kelompok vitamin E+plasebo (151.9:l:22.l mg/dl.) meningkat sedangkan kelompok vitamin E+C (l46.8:b28.2l mg/dL) menurun. Sebelum perlakuan, nilai median kadar MDA plasma kelompok vitamin E+plasebo dan rerata kadar MDA plasma kelompok vitamin E-+C masing-musing adalah 2.63(l .92-4.42) nmol/mL dan 3.03=h0.62 nmol/mL. Setelah 45 hari perlakuan rerata kadar MDA plasma kedua kelompok mcnurun menjadi 2.30:h0.67 nmol/mL (p<0.0l) pada kelompok vitamin E+plasebo dan 2.88i:0.88 mnol/mL (p=0.36) untuk kelompok vitamin E+C. Penurunan kadar MDA plasma kelompok vitamin E+plaseb0 lebih besar (-0.5=\=0.55 nmol/mL) daripada kclompok vitamin E+C (-0.28(1.3l-1.63) nmol/mL), tetapi dengan uji statistik terhadap kedua nilai tersebut, tidak berbeda berma.kna(p=0.09). Pemberian kombinasi vitamin E dan vitamin C pada usila dengan hiperkolesterolemia tidak dapat menurunkan kadar MDA plasma lebih besar dibandingkan dcngan hanya pemberian vitamin E. Usia lanjut, hipcrkolcstcrolcmia, vitamin E, vitamin C, malondiaidehida.

---

The eH'ect of combined supplementation of vitamin E and C on plasma Malondyaldehyde level elderly with hypercholesterolemic. To know the effect of combined supplementation of vitamin E and C in lipid peroxidation in hypercholesterolemic elderly. This parallel, single blind, randomization clinical trial purpose was to compare plasma malondyaldehyde level in hypercholesterolemic elderly aged more than 60 years old. Forty two people Hom Yayasan Kebagusan, Yayasan Yasni and Yayasan Yakin, Pasar Minggu, South Jakarta which participated the study, were divided into two groups. Twenty one elderly were supplemented with 400 IU vitamin E and 500 mg vitamin C for 45 consecutive days, while the other group was supplemented with 400 IU vitamin E and placebo. The data of demographic, anthropometrics, food intake in the first, third and seventh weeks, plasma LDL and MDA levels before and aller period were taken. Statistical analyzes was perfonned by SPSS 11.5.

Twenty people for each group had followed the study until the end of period. Before study, LDL cholesterol median for vitamin E + placebo group and vitamin E+C group were l46.SO(I30-190) mg/dL and l46.50{l30»l90) mg/dL respectively. After 45 of days treatment, there was an increase in mean LDL cholesterol in vitamin E + placebo group l5l.9:l:22.l mg/dl, while in vitamin E+C group was decreased to l46.8i28.2I mg/dL. Before study, plasma MDA level in vitamin E -I- placebo group and vitamin E+C group were 2.63(l .92-4.42) and 3.03i0.62 nmol/mL, respectively. Alter 45 days, mean MDA plasma in vitamin E + placebo group was 2.30-£0.67 nmol/mL (p<0.0l) and was 2.88:t0.88 nmol/mL (p=0.36) in vitamin E+C group. The decreased on plasma MDA levels in vitamin Er*-placebo group was higher (-0510.55 nmol/mL) than vitamin E+C (-0.28(l.31-1.63) nmol/mL), but statistical test showed not significant different between both group (p=0.09). Combined supplementation vitamin E and vitamin C in hypercholesterolemic elderly eouldnot decrease plasma MDA higher than supplementation of vitamin E alone."

"Angka prevalensi hipertensi terus meningkat di dunia. Berdasarkan data Riskesdas 2018, prevalensi hipertensi di Indonesia cukup tinggi yaitu sebesar 34,1%. Salah satu faktor risiko hipertensi yang dapat dirubah adalah hiperkolesterol. Hasil skriningpemeriksaan kesehatan para pekerja di Bandara Soekarno Hatta menunjukkan angka kasus hiperkolesterol yang cukup tinggi. Tujuan penelitian ini adalah untuk mengetahui besar asosiasi antara hiperkolesterol dengan kejadian hipertensi derajat 1 pada pekerja di Bandara Soekarno Hatta. Penelitian ini menggunakan desain studi cross-sectionaldari data sekunder kegiatan Posbindu PTM Kantor Kesehatan Pelabuhan Soekarno Hatta tahun 2017. Subyek penelitian adalah pekerja di instansi pemerintah dan BUMN di wilayah Bandara Soekarno Hatta yang melakukan pemeriksaan kesehatan di Posbindu PTM pada tahun 2017 yaitu sebanyak 411 orang. Penelitian ini menggunakan analisis multivariat cox regression dan besar pengaruh dinyatakan dalam prevalensi rasio (PR). Hasil menunjukkan bahwa prevalensi kejadian hipertensi derajat 1 pada pekerja yang hiperkolesterol sebesar 28,4%. Kadar kolesterol tinggi berisiko sebesar 1,19 (95% CI: 0,73-1,96) untuk dapat mengalami hipertensi derajat 1. Mengoptimalkan kegiatan Posbindu PTM di tempat kerja diharapkan dapat mengendalikan hiperkolesterol dan hipertensi.

---

The prevalence of hypertension continues to increase in the world. Based on Riskesdas 2018, the prevalence of hypertension in Indonesia is quite high at 34,1%. One of the risk factor for hypertension that can be changed is hypercholesterolemia. The results of health examinations screening of employees at Soekarno Hatta Airport in 2017 showed a high rate of hypercholesterolemia. The purpose of this study was to determine the magnitude of the association between hypercholesterolemia and the incidence of first stage hypertension in employees at Soekarno Hatta Airport. This study used a cross sectional design from secondary data on Posbindu PTM activities in the Soekarno Hatta Port Health Office in 2017. The research subjects were employees in government agencies and BUMN at Soekarno Hatta Airport who conducted health checks at Posbindu PTM in 2017, totaling 411 people. This study uses multivariate cox regression analysis and the magnitude of the effect was expressed in the prevalence ratio (PR). The results showed that the prevalence of stage 1 hypertension in employees with hypercholesterolemia was 28,4%. High cholesterol levels have a risk of 1,19 (95% CI: 0,73-1,96) to cause stage 1 hypertension. Optimizing Posbindu PTM activities in the workplace is expected to control hypercholesterolemia and hypertension"

"Penyakit kardiovaskular merupakan penyebab kematian nomor satu di dunia dengan prevalensi yang semakin meningkat dari tahun ke tahun. Aterosklerosis merupakan penyebab utama dari penyakit kardiovaskular, dapat dideteksi dini dengan pemeriksaan ultrasonografi ketebalan intima-media KIM karotis. Salah satu faktor risiko aterosklerosis yang dapat dimodifikasi adalah dislipidemia, dapat dipengaruhi dari asupan makanan antara lain diet tinggi fruktosa. Fruktosa selain dalam bentuk alami juga banyak digunakan secara komersial sebagai pemanis makanan/minuman. Penelitian dengan desain potong lintang ini bertujuan untuk mengetahui korelasi asupan fruktosa dengan KIM karotis pada laki-laki hiperkolesterolemia usia 19 ??49 tahun. Dari 47 subjek yang merupakan karyawan RS Jantung dan Pembuluh Darah Harapan Kita Jakarta, didapatkan nilai tengah usia subjek 41 33 ??45 tahun. Sebanyak 57,4 subjek memiliki kadar low density lipoprotein LDL tinggi dan sangat tinggi, 29,8 kadar high density lipoprotein HDL rendah dan 27,6 kadar trigliserida tinggi dan sangat tinggi. Sebagian besar subjek memiliki tekanan darah sistolik dan diastolik normal. Sebanyak 72,3 subjek tergolong obesitas dan 66,0 tergolong obesitas sentral. Sebagian besar subjek merupakan perokok ringan dan sebanyak 48,9 subjek beraktivitas ringan. Pada pemeriksaan KIM karotis didapatkan nilai tengah 1 0,8 ??1,4 mm dengan 63,8 subjek terdapat penebalan. Nilai tengah asupan energi total 1209 1020 ??1645 kkal/hari, asupan karbohidrat, protein, lemak sebagian besar tergolong cukup, asupan serat 100 tergolong kurang dan rerata asupan fruktosa 31,97 ? 15,48 gram/hari. Hasil analisis bivariat tidak terdapat korelasi antara asupan fruktosa dengan KIM karotis namun terdapat korelasi positif bermakna antara lingkar pinggang dan asupan lemak dengan KIM karotis. Hasil analisis multivariat didapatkan bahwa asupan lemak mempunyai hubungan bermakna dengan KIM karotis.

---

Cardiovascular disease is the number one cause of death worldwide with an increasing prevelance annually. Atherosclerosis is the main cause of cardiovascular disease that is detectable early by ultrasound examination of the intima media thickness IMT of the carotid artery. One of the modifiable risk factors for developing atherosclerosis is dyslipidemia, that can be affected by food intake among them is high fructose diet. Apart from naturally occurring, fructose is largely used commercially as food beverage sweetener. This cross sectional study was conducted to investigate the correlation between fructose intake and IMT in male subjects with hypercholesterolemia aged 19 49 years old. Of 47 subjects who are Harapan Kita National Cardiovascular Center Hospital s employee, median age was 41 33 45 years old. In 57.4 subjects, low density lipoprotein LDL was found high and very high, 29.8 subjects have low high density lipoprotein HDL levels, and 27.6 subjects have high and very high triglycerides levels. Most subjects have normal systolic and diastolic blood pressure. Around 72.3 subjects were classified as obesity and 66.0 were classified as having central obesity. Majority of subjects were light smoker and 49.8 of them performed light activity. In carotid IMT examination, median of 1 0.8 1.4 mm was found with 63.8 subjects developed thickness. Median total energy intake was 1209 1020 1645 Kcal day, mostly with adequate carbohydrate, protein, and fat, fiber intake was inadequate in 100 subjects, and mean fructose intake of 31,97 15,48 gram day. Bivariate analysis did not demonstrate any correlation between fructose intake and carotid IMT however there was positive correlation between waist circumference and fat intake with carotid IMT. Multivariate analysis showed that fat intake has a significant correlation with carotid IMT."

"Hiperkolesterolemia merupakan salah satu prediktor kuat berbagai penyait jantung yang merupakan penyebab utama kematian di dunia. Penelitian ini bertujuan untuk mengetahui apakah ada perbedaan berbagai faktor yang berkaitan dengan kejadian hiperkolesterolemia pada penderita diabetes melitus di Puskesmas Pasar Minggu pada tahun 2018. Penelitian ini menggunakan metode cross-sectional dengan jumlah sampel sebesar 126 responden menggunakan consecutive sampling. Variabel penelitian yang diteliti adalah kejadian hiperkolesterolemia, jenis kelamin, lama menderita diabetes melitus, riwayat DM keluarga, kebiasaan merokok, aktivitas fisik, tingkat stress, persen lemak tubuh dan asupan lemak. Hasil dari penelitian ini menunjukkan bahwa prevalensi kejadian hiperkolesterolemia pada penderita DM adalah 56,3% dengan 37,1% pada pria dan 63,7% pada wanita. Dari seluruh variabel independent yang diteliti, perbedaan yang bermakna dengan hasil uji chi square terdapat pada variabel jenis kelamin (OR = 2,947; CI = 1,326-6,672), riwayat keluarga (OR = 0,443; CI = 0,209-0,895) dan kebiasaan merokok (OR = 1,233; CI = 0,990-11,898). Sementara itu, tidak terdapat perbedaan bermakna kejadian hiperkolesterolemia berdasarkan lama menderita DM, aktivitas fisik, tingkat stress, antropometri dan asupan lemak karena p > 0,05. Untuk menyimpukan, terdapat perbedaan yang signifikan pada jenis kelamin, riwayat DM keluarga dan kebiasaan merokok dengan kejadian hiperkolesterolemia, dengan peningkatan risiko hiperkolesterolemia sejalan dengan jenis kelamin perempuan, adanya riwayat DM keluarga dan kebiasaan aktif merokok

---

Hypercholesterolemia is the leading predictor of various cardiac disease (CVD) which is the leading cause of death in the world. This study aims to determine whether there are any differences the incidence of hypercholesterolemia based on factors related to it in people with diabetes mellitus at Pasar Minggu Primary Health Care in 2018. This study used a cross-sectional method with a sample size of 126 respondents using consecutive sampling. Research variables studied were incidence of hypercholesterolemia, sex, duration of diabetes mellitus, family history of diabetes mellitus, smoking habit, physical activity, stress level, body fat percentage and fat intake. The results of this study showed that the prevalence of hypercholesterolemia incidence in DM patients was 56.3% with 37.1% in men and 63.7% in women. Of all independent variables studied, significant differences with statistical analysis were in sex (OR = 2.947, p = 0.009), family history (OR = 0.443, p = 0.018) and smoking habits (OR = 1,233; p = 0.038). Meanwhile, there was no significant the incidence of hypercholesterolemia differences based on duration of diabetes mellitus, physical activity, stress level, anthropometry and fat intake due to p > 0.05. To conclude, there were significant differences in sex, family history of diabetes mellitus and smoking habits with hypercholesterolaemia incidence, with an increased risk of hypercholesterolemia in line with female sex, family history of DM and active smoking habits."

"Kurangnya pemahaman mengenai makanan sehat dan gaya hidup saat ini telah menjadi faktor yang mengarah pada penyakit metabolik, seperti hiperkolesterolemia. Hiperkolesterolemia merupakan salah satu faktor risiko aterosklerosis dan sering disebabkan oleh asupan makanan, terutama konsumsi tinggi lemak dan asam lemak jenuh saturated fatty acids, SFA sedangkan asam lemak tidak jenuh tunggal monounsaturated fatty acid, MUFA dan asam lemak tidak jenuh jamak polyunsaturated fatty acid, PUFA diketahui memiliki korelasi negatif terhadap risiko penyakit kardiovaskular. Penelitian potong lintang ini bertujuan untuk mencari hubungan antara asupan asam lemak jenuh dan tidak jenuh dengan kadar kolesterol LDL dan apolipoprotein B apoB darah pada karyawan laki-laki hiperkolesterolemia berusia 19-49 tahun. Penelitian ini diikuti oleh 52 subjek, pengumpulan data asupan makanan menggunakan metode food recall 24 jam dan semi-quantitative food frequency questionnaire SQFFQ , pemeriksaan antropometri untuk mendapatkan indeks massa tubuh IMT dan lingkar pinggang, dan pemeriksaan darah untuk mengetahui kadar kolesterol LDL dan apoB. Hasil penelitian menunjukkan bahwa kadar kolesterol LDL memiliki korelasi yang bermakna dengan asupan SFA tetapi tidak dengan asupan lemak total, MUFA, dan PUFA. Kadar apoB memiliki korelasi yang bermakna dengan kadar kolesterol LDL tetapi tidak dengan asupan lemak total, SFA, MUFA, dan PUFA.

---

Lack of understanding about healthy food and today lifestyle have been issues towards metabolic diseases, such as hypercholesterolemia. Hypercholesterolemia is one of the risk factors in atherosclerosis and often caused by dietary intake, especially consumption of high fat and high saturated fatty acids SFA while monounsaturated fatty acids MUFA and polyunsaturated fatty acids PUFA intake are known inversely correlated with cardiovascular disease CVD risks. This cross sectional study was aimed to determine the correlation between saturated and unsaturated fatty acids intake with serum low density lipoprotein cholesterol LDL C and apolipoprotein B apoB levels in hypercholesterolemic male employees aged 19 to 49 years. The study was conducted using 52 subjects, data collection of food intake using 24 hour food recall and semi quantitative food frequency questionnaire SQFFQ , anthropometric measurements for body mass index BMI and waist circumference WC , and blood examination for serum LDL C and apoB levels. The result of this study showed that LDL C levels was correlated with SFA intake but not with total fat, MUFA and PUFA intake. ApoB levels was correlated with LDL C levels but not with total fat, SFA, MUFA and PUFA intake."

"Fitosterol merupakan salah satu senyawa aktif yang dapat menurunkan kadar kolesterol. Sumber fitosterol yang digunakan dalam penelitian ini berasal dari bahan alami yaitu daun keji beling (Strobilanthes crispus). Metode ekstraksi yang digunakan adalah menggunakan bantuan gelombang mikro dengan alat Microwave Assisted Extraction (MAE), dengan pelarut n-heksana teknis. Waktu ekstraksi tertinggi adalah 15 menit dengan % fitrat ekstrak sebesar 33,92 %. Proses selanjutnya adalah pemurnian atau isolasi fitosterol dengan metode kolom kromatografi dengan beberapa trial pelarut. Pemurnian atau isolasi fitosterol yang terbaik yaitu dengan menggunakan eluen pelarut kloroform teknis : etanol 96% dengan perbandingan volume (9:1). Selanjutnya diidentifikasi secara semikuantitatif dengan menggunakan LC/MS. LC/MS mengidentifikasi fitosterol berdasarkan berat molekunya (BM). Langkah terakhir adalah uji in vitro fitosterol dari hasil crude extract, dimana fitosterol mampu menurunkan kadar kolesterol paling tinggi dengan massa 0,3 mg.

---

Phytosterol is one of active compound that can down cholesterol rate. Phytosterol source that is utilized in this research is material natural which is keji beling leaves (Strobilanthes crispus). Extraction method is used microwave help with tool Microwave Assisted Extraction (MAE), with normal hexane solvent. The higest extraction time is 15 minute with % fitrate extracts is 33,92 %. The next step is purification or isolation of phytosterol by chromatography column with trial solvent. Phytosterol’s purification or isolation the best one which is by use of eluen technical chloroform dissolving : ethanol 96% by volume compares (9:1). The identified semi quantitative by use of LC/MS. LC/MS identifies phytosterol bases molekunya's weight (BM). Last stage is test in vitro phytosterol of result crude extract, where can phytosterol down highest cholesterol rate with mass 0,3 mg phytosterol."

"Antioksidan digunakan untuk meredam reaksi pembentukan radikal bebas di dalam tubuh. Quercetin dari ekstrak daun Keji Beling dapat dijadikan sebagai sunber antioksidan alami. Ekstraksi senyawa quercetin dari daun Keji Beling dengan metode sonikasi menghasilkan rendemen sebesar 10,67%. Berdasarkan uji fitokimia ekstrak daun Keji Beling didapatkan perubahan warna dari coklat menjadi jingga kecoklatan yang menunjukkan adanya kandungan flavonoid. Isolasi quercetin dilakukan dengan kromatografi kolom dan kromatografi lapis tipis. Eluen yang digunakan dalam isolasi quercetin dari ekstrak daun Keji Beling adalah methanol-etil asetat (4:1). Dari hasil pengujian dengan FTIR dan NMR didapatkan gugus-gugus senyawa yang umumnya terkandung dalam senyawa quercetin yaitu fenol, aromatic, karbonil, alkana, dan eter.

---

Antioxidant is used to prevent free radical forming in body. Quercetin from Keji Beling leaves extract can be used as natural antioxidant source. The extraction of quercetin from Keji Beling leaves with sonication method produce a yield of 10,67%. Based on phytochemical test of Keji Beling leaves extract obtained changes color from brown to reddish brown that indicates the flavonoid. Isolation of quercetin was conducted by using colomn chromatography and thin layer chromatography. The eluent that used for isolation of quercetin is methanol-etil acetate (4:1). From the test result of FTIR and NMR were obtained the function groups from sampel and also obtained in quercetin are phenol, aromatic, carbonil, alkane, and ether."

"Diabetes melitus sering disebut sebagai the great imitator karena merupakan salah satu penyakit paling membahayakan di dunia. Daun keji beling (Strobilanthes crispus) sudah banyak dimanfaatkan sebagai obat tradisional untuk mengatasi berbagai penyakit, salah satunya adalah diabetes melitus. Pada penelitian ini, daun keji beling diekstrak menggunakan ultrasonikasi dan ATPS (Aqueous Two-Phase System) dengan praperlakuan hidrolisis enzimatik yang metodenya divariasikan. Senyawa-senyawa pada ekstrak kasar diisolasi menggunakan kromatografi kolom yang komposisi fasa geraknya divariasikan. Ekstrak kasar dan isolat-isolatnya diujikan aktivitas antidiabetes dengan uji penghambatan α-glukosidase dan ditentukan struktur senyawanya dengan LC-MS/MS- Q-TOF. Hasil pengujian kualitatif dengan reagen Benedict dan Scanning Electron Microscopy (SEM) menunjukkan bahwa penggunaan enzim selulase pada ekstraksi daun keji beling dapat mendegradasi dinding sel dan meningkatkan yield ekstraksi hingga lebih dari dua kali lipat. Penggunaan ATPS pada ekstraksi daun keji beling meningkatkan kemurnian zat aktif dengan menarik senyawa pengotor ke fasa bawah ATPS yang terbukti dengan penurunan rendemen dari fasa atas ekstrak daun keji beling. Sembilan (9) senyawa berhasil diidentifikasi dari ekstrak etanol daun keji beling dengan metode ekstraksi terbaik, yaitu ekstraksi UAEE dan ATPS simultan (yield ekstraksi = 48,97%). Enam (6) senyawa dari ekstrak tersebut berhasil diisolasi dengan komposisi fasa gerak terbaik (toluena:etil asetat, 1:1 v/v). Aktivitas antidiabetes dianalisis dengan metode inhibisi enzim α-glukosidase. Ekstrak etanol daun keji beling memiliki harga IC50 sebesar 390,35 μg/mL. Fraksi V menunjukkan aktivitas antidiabetes terbaik (IC50 = 201,87 μg/mL) dengan jenis inhibisi campuran terhadap α-glukosidase (Vmax = 0,525 μM/menit; KM = 1,040 μM). Hasil dari LC-MS/MS-Q-TOF menunjukkan bahwa fraksi V teridentifikasi sebagai kaempferol (m/z ion induk = 287,0535) dengan kandungan kaempferol dalam ekstrak etanol daun keji beling adalah 24,29%.

---

Diabetes mellitus is often referred to as the great imitator because it is one of the most dangerous diseases in the world. Keji beling leaves (Strobilanthes crispus) have been widely used as a medicine to treat various diseases, one of which is diabetes mellitus. In this research, keji beling leaves were pretreated using enzymatic hydrolysis and extracted using ultrasonication and ATPS (Aqueous Two-Phase System) with varied methods. The compounds in the crude extract were isolated using column chromatography in which the mobile phase composition was varied. The crude extract and the isolates were tested for antidiabetic activity with α-glucosidase inhibition test and the structure of the compounds was determined using LC-MS/MS-Q-TOF. The results of qualitative tests using Benedict reagent and Scanning Electron Microscopy (SEM) showed that cellulase degraded cell wall and increased the yield of extraction more than two-fold. The application of ATPS in keji beling leaves extraction increased the purity of active compounds by transferring the impurities to the bottom phase which is shown by the decrease of the rendement of the top phase of keji beling leaves extract. Nine (9) compounds were identified in keji beling leaves ethanol extract using the best extraction method, which is simultaneous UAEE and ATPS extraction (extraction yield = 48.97%). Six (6) compounds of the extract were isolated using the best mobile phase composition (toluene:ethyl acetate, 1:1 v/v). The antidiabetic activity is analyzed using inhibition of α-glucosidase enzyme method. Keji beling leaves ethanol extract has the IC50 value of 390.35 μg/mL. Fraction V showed the best antidiabetic activity (IC50 = 201.87 μg/mL) with the type of mixed inhibition towards α-glucosidase (Vmax = 0.525 μM/min; KM = 1.040 μM). The results of LC-MS/MS-Q-TOF showed that fraction V was identified as kaempferol (m/z parent ion = 287.0535), which is contained 24.29% in keji beling leaves ethanol extract."

"[ ABSTRAK Keji Beling (Strobilanthes crispus) merupakan salah satu tanaman yang dapat dimanfaatkan sebagai antihiperkolesterolemia dengan senyawa aktif fitosterol. Pembuatan nanopartikel keji beling sebagai penghantar obat dilakukan untuk mencapai efektivitas obat menuju organ target. Penelitian ini bertujuan mendapatkan gambaran profil pelepasan nanopartikel keji beling pada media fluida sintetik dengan variasi konsentrasi penyalutnya serta pengujian inhibisi ekstrak keji beling dalam menghambat enzim HMG KoA Reduktase. Penelitian terdiri atas 4 tahap yaitu ekstraksi keji beling, pembuatan nanopartikel, uji profil pelepasan serta uji inhibisi enzim HMG koA Reduktase. Penelitian ini menghasilkan nanopartikel dengan efisiensi penyalut terbesar(94,64%) pada Kitosan 1% : STPP 1%, dan loading capacity terbesar (31,28%) diperoleh pada variasi Kitosan 1% :1,5%. Profil pelepasan dengan karakter penyalut yang resisten pada kondisi lambung diperoleh oleh variasi Kitosan 1%:1,5%. Determinasi analitis secara FTIR membuktikan bahwa ekstrak telah tersalut dalam penyalutnya yang dibuktikan dengan adanya gugus alkohol. Morfologi FESEM dengan ukuran partikel terkecil diperoleh pada variasi kitosan 1%: STPP 1% dengan ukuran terkecil 132 nm. Penurunan kadar kolesterol oleh daun keji beling terjadi melalui penghambatan enzim HMG KoA Reduktase. Penelitian ini membuktikan bahwa ekstrak keji beling mampu berperan sebagai inhibitor dalam menghambat enzim HMG-KoA dengan persentase inhibisi 15%-17,8%.

---

ABSTRACT Nasty Shard (Strobilanthes crispus) is one of herbs that utilized as antihypercholesterolemia with phytosterol as active compound. Producing nanoparticle of nasty shard as drug delivery is to obtain efectiveness drug to released target. This research was design to obtain released profile assay of nasty shard nanoparticle in simulated digestive fluid with concentration variation of nanoparticle and inhibition assay of nasty shard extract to inhibit HMG CoA Reductase.This resarch consist of 4 stages those are extraction of nasty shard leaves, nanoparticle designed, release profile assay and inhibition assay of HMG CoA Reductase. This research produce nanoparticle with highest encapsulation efficiency (94,64%) obtained by chitosan concentration 1% and STPP 1%, while the highest loading capacity (31,28%) was obtained by chitosan concentration 1% and STPP 1,5%. Released profile assay show nanoparticle characteristic which resistant in gastric condition with chitosan consentration 1% and STPP 1,5%. FTIR analysis show extract has encapsulated by alcohol group. Morphology by FESEM of smallest particle sized (132 nm) Obtained by chitosan concentartion 1% and STPP 1,5%. The decreasing of cholesterol by extract through inhibit HMG CoA Reductace. This research shown nasty shard leaves extract is capabable of acting as inhibitor of HMG CoA Reductase enzime with percentage inhibition from15%-17,8%

;Nasty Shard (Strobilanthes crispus) is one of herbs that utilized as antihypercholesterolemia with phytosterol as active compound. Producing nanoparticle of nasty shard as drug delivery is to obtain efectiveness drug to released target. This research was design to obtain released profile assay of nasty shard nanoparticle in simulated digestive fluid with concentration variation of nanoparticle and inhibition assay of nasty shard extract to inhibit HMG CoA Reductase.This resarch consist of 4 stages those are extraction of nasty shard leaves, nanoparticle designed, release profile assay and inhibition assay of HMG CoA Reductase. This research produce nanoparticle with highest encapsulation efficiency (94,64%) obtained by chitosan concentration 1% and STPP 1%, while the highest loading capacity (31,28%) was obtained by chitosan concentration 1% and STPP 1,5%. Released profile assay show nanoparticle characteristic which resistant in gastric condition with chitosan consentration 1% and STPP 1,5%. FTIR analysis show extract has encapsulated by alcohol group. Morphology by FESEM of smallest particle sized (132 nm) Obtained by chitosan concentartion 1% and STPP 1,5%. The decreasing of cholesterol by extract through inhibit HMG CoA Reductace. This research shown nasty shard leaves extract is capabable of acting as inhibitor of HMG CoA Reductase enzime with percentage inhibition from15%-17,8%

, Nasty Shard (Strobilanthes crispus) is one of herbs that utilized as antihypercholesterolemia with phytosterol as active compound. Producing nanoparticle of nasty shard as drug delivery is to obtain efectiveness drug to released target. This research was design to obtain released profile assay of nasty shard nanoparticle in simulated digestive fluid with concentration variation of nanoparticle and inhibition assay of nasty shard extract to inhibit HMG CoA Reductase.This resarch consist of 4 stages those are extraction of nasty shard leaves, nanoparticle designed, release profile assay and inhibition assay of HMG CoA Reductase. This research produce nanoparticle with highest encapsulation efficiency (94,64%) obtained by chitosan concentration 1% and STPP 1%, while the highest loading capacity (31,28%) was obtained by chitosan concentration 1% and STPP 1,5%. Released profile assay show nanoparticle characteristic which resistant in gastric condition with chitosan consentration 1% and STPP 1,5%. FTIR analysis show extract has encapsulated by alcohol group. Morphology by FESEM of smallest particle sized (132 nm) Obtained by chitosan concentartion 1% and STPP 1,5%. The decreasing of cholesterol by extract through inhibit HMG CoA Reductace. This research shown nasty shard leaves extract is capabable of acting as inhibitor of HMG CoA Reductase enzime with percentage inhibition from15%-17,8%

]"